Literature DB >> 8386896

Quantitative evaluation of electron transport system proteins in mitochondrial encephalomyopathy.

K Haginoya1, S Miyabayashi, K Iinuma, K Tada.   

Abstract

The levels of mitochondrial electron transport system proteins cytochrome c oxidase (COX) and complex III were measured in muscle fibers of patients with mitochondrial encephalomyopathy using quantitative immunoelectron microscopy. In a patient with Leigh's encephalopathy, immunoreactive COX protein was decreased to 20% of the normal mean value in all muscle fibers examined, while the amount of complex III was within the normal range. In a patient with fatal infantile COX deficiency, the level of COX protein was found to be decreased to 27-40% of the normal value in all muscle fibers examined. In patients with mitochondrial myopathy, encephalopathy, lactic acidosis associated with stroke-like episodes (MELAS) and chronic progressive external ophthalmoplegia (CPEO), COX protein levels were decreased to 20% of normal in muscle fibers lacking COX activity. In normal fibers, however, COX protein levels were also normal. The amount of complex III protein was normal in COX-deficient muscle fibers. In two patients, in situ hybridization was performed for detection of mitochondrial mRNA. Mitochondrial mRNAs were found to be abundant in muscle fibers with decreased COX protein, suggesting a defect at the mitochondrial protein-synthesis level in a COX-deficient muscle fiber.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386896     DOI: 10.1007/bf00334446

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

1.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

2.  Tissue specificity in cytochrome c oxidase deficient myopathy.

Authors:  I Nonaka; Y Koga; E Ohtaki; M Yamamoto
Journal:  J Neurol Sci       Date:  1989-09       Impact factor: 3.181

3.  Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation.

Authors:  J M Shoffner; M T Lott; A M Lezza; P Seibel; S W Ballinger; D C Wallace
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

4.  Cytochrome C oxidase deficiency in two siblings with Leigh encephalomyelopathy.

Authors:  S Miyabayashi; K Narisawa; K Iinuma; K Tada; K Sakai; K Kobayashi; Y Kobayashi; S Morinaga
Journal:  Brain Dev       Date:  1984       Impact factor: 1.961

5.  Mitochondrial DNA polymorphism in Japanese. I. Analysis with restriction enzymes of six base pair recognition.

Authors:  S Horai; T Gojobori; E Matsunaga
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Mosaicism of mitochondria in mitochondrial myopathy: an electronmicroscopic analysis of cytochrome c oxidase.

Authors:  K Haginoya; S Miyabayashi; K Iinuma; K Tada
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Multiple cytochrome deficiency and deteriorated mitochondrial polypeptide composition in fatal infantile mitochondrial myopathy and renal dysfunction.

Authors:  M Tanaka; M Nishikimi; H Suzuki; T Ozawa; E Okino; H Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1986-06-13       Impact factor: 3.575

8.  Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome.

Authors:  C T Moraes; S DiMauro; M Zeviani; A Lombes; S Shanske; A F Miranda; H Nakase; E Bonilla; L C Werneck; S Servidei
Journal:  N Engl J Med       Date:  1989-05-18       Impact factor: 91.245

9.  Cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence for a nuclear DNA-encoded mutation.

Authors:  A F Miranda; S Ishii; S DiMauro; J W Shay
Journal:  Neurology       Date:  1989-05       Impact factor: 9.910

10.  Cytochrome C oxidase-deficient mitochondria in mitochondrial myopathy.

Authors:  K Haginoya; S Miyabayashi; K Iinuma; E Okino; H Maesaka; K Tada
Journal:  Pediatr Neurol       Date:  1992 Jan-Feb       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.